As we continue to cope with the ongoing coronavirus pandemic nationwide, a second public health crisis is emerging and causing increasing alarm. Stemming from the initial deferrals of routine care as the pandemic took hold, combined with shelter-in-place health orders and the fears generated by ...

With 34,210 new diagnoses projected this year in the United States,1 meningiomas are the most common primary brain tumor. While the majority of meningiomas are low grade and typically respond well to surgery and radiotherapy, high grade meningiomas are still poorly understood and often recur despite treatment.

On October 4th, Alain Algazi, MD, a melanoma specialist and head-and-neck cancer researcher at UCSF, will join friends and colleagues in running a marathon across SF and Marin to benefit the American Cancer Society. The ambitious 26.5 mile course will begin at the Hi Dive Bar ...

A malignant tumor is a bustling metropolis populated by many different kinds of cancer cells. This cellular diversity, however, is what makes cancer so difficult to treat, as each type of cell in a tumor responds differently – and sometimes not at all – to ...

UC San Francisco scientists have launched a precision medicine initiative to offer free voluntary whole genome sequencing to all UCSF Health patients – making it the most comprehensive program of its kind in the nation. The goal of the initiative, called the UCSF 3D Health Study (for “Data, Discovery, ...